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in rats (Satoh and Fibiger, 1986; Hallanger et al., 1987; Cornwall 
et al., 1990). The extent to which projections from the LDT and the 
PPT have distinct functions is unclear; nonetheless, the similarities 
in their projection patterns to most thalamic nuclei suggest that 
the contributions are similar across the many systems represented 
by those thalamic nuclei. The possible lack of a projection from 
the LDT to the MG suggests that the auditory thalamus may be 
exceptional in receiving a unique pattern of cholinergic inputs from 
the brainstem.
Another question concerns the types of cells in the PMT that 
project to the thalamus. The PPT and the LDT are known as cholin-
ergic nuclei, but contain a variety of cell types, including distinct 
populations of cholinergic, glutamatergic, and GABAergic neurons 
(Boucetta and Jones, 2009; Wang and Morales, 2009). Recently there 
has been increasing interest in the contribution of non-cholinergic 
cells to the functions ascribed to the PMT. For example, Boucetta 
and Jones (2009) have recorded the physiological activity of 
cholinergic, glutamatergic, and GABAergic cells in the PMT and 
have suggested that all three cell types act in concert to control 
behavioral states across the sleep-wake cycle. Previous studies have 
acknowledged a non-cholinergic PMT projection to the thalamus 
(Steriade et al., 1988), but the relative number of cholinergic and 
non-cholinergic cells contributing to the projection is unknown 
for the MG and for most thalamic targets.
We used a combination of retrograde tracers and immunohisto-
chemistry to examine the projection from the PMT to the MG. We 
describe the relative contributions of the PPT and the LDT to the pro-
jection, the proportions of ipsilateral and contralateral projections, and 
the proportions of cholinergic and non-cholinergic components.
IntroductIon
The medial geniculate body (MG) is part of the auditory thalamus 
and serves as the primary source of ascending input to the auditory 
cortex. The MG, like other thalamic nuclei, is under the influence of 
projections from the brainstem cholinergic nuclei (Mesulam et al., 
1983; Steriade et al., 1988; Oakman et al., 1999). These projections 
arise from the pedunculopontine tegmental nucleus (PPT) and 
the laterodorsal tegmental nucleus (LDT), collectively referred to 
as the pontomesencephalic tegmentum (PMT). The cholinergic 
projections form part of the ascending arousal system and, as such, 
control the firing mode of thalamic cells through both nicotinic 
and muscarinic effects (Tebecis, 1972; McCormick and Prince, 
1987; Steriade et al., 1988; Jones, 2005). These effects control the 
flow of information to the cortex and underlie changes in tha-
lamic responsiveness during the sleep-wake cycle and at varying 
levels of arousal during wakefulness (Edeline, 2003; Steriade, 2004; 
Hennevin et al., 2007).
There have been numerous studies of cholinergic innervation 
of the thalamus and a general pattern of projections has emerged 
(Shute and Lewis, 1967; Hallanger et al., 1987; Steriade et al., 1988). 
The PPT contributes more cells than the LDT to the thalamic pro-
jections. Both nuclei project bilaterally with an ipsilateral domi-
nance (Steriade et al., 1988). It has been reported that up to 85% of 
the PMT projection to thalamic relay nuclei is cholinergic (Steriade 
et al., 1988). None of the studies have focused exclusively on the 
MG, but Steriade et al. (1988) reported that the projection to the 
MG in cats follows the general pattern described above. In contrast, 
results from both retrograde and anterograde tracing experiments 
have reported that there is no projection to the MG from the LDT 
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MaterIals and Methods
During all experiments, efforts were made to minimize suffering 
and the number of animals used. All procedures were performed in 
accordance with the Institutional Animal Care and Use Committee 
and the National Institutes of Health guidelines on the ethical use 
of animals. Twelve pigmented guinea pigs (Elm Hill; Chelmsford, 
MA, USA) of either gender weighing 250–500 g were used.
surgery
Sterile instruments and aseptic technique were used for all surgi-
cal procedures. Each animal was anesthetized with isoflurane (4% 
for induction, 1.5–2.5% for maintenance) in oxygen. The animal’s 
head was shaved and cleansed with Betadine (Purdue Products 
L.P., Stamford, CT, Rochester, NY, USA). Ophthalmic ointment 
(Moisture Eyes PM, Bausch & Lomb, Rochester, NY, USA) was 
applied to each eye. Atropine sulfate (0.05 mg/kg, i.m.) was adminis-
tered to decrease respiratory secretions during surgery, and Ketofen 
(ketoprofen 3 mg/kg, i.m.; Henry Schein, Melville, NY, USA) was 
given for post-operative pain control. The animal was positioned 
with its head in a stereotaxic frame. A feedback-controlled heating 
pad was used for maintaining the animal’s body temperature.
An incision was made in the scalp and the wound edges were 
injected with Marcaine (0.25% bupivacaine with epinephrine 
1:200,000; Hospira, Inc., Lake Forest, IL, USA). A dental drill was used 
to make a small hole in the skull. Details about the tracers used and 
the injection parameters for each case are provided in Table 1. After 
the tracer injection, the opening in the skull was covered with Gelfoam 
(Harvard Apparatus, Holliston, MA, USA). The scalp was sutured. 
Anesthesia was then discontinued and the animal was removed from 
the stereotaxic frame and placed in a clean cage. The animal was moni-
tored in its cage until it was ambulatory and able to eat and drink.
PerfusIon and sectIonIng
After surgery, the animal remained in the animal care facility for 
4–25 days to allow for transport of the tracers. The animal was 
given an overdose of either sodium pentobarbital (440 mg/kg, i.p.) 
or isoflurane (5% in oxygen, inhaled). After cessation of breathing 
and loss of the withdrawal reflex, the animal was perfused through 
the vascular system with Tyrode’s solution, then 250 ml of 4% 
paraformaldehyde in 0.1 M phosphate buffer, pH 7.4, followed by 
250 ml of the same fixative with 10% sucrose added. The brain was 
removed and placed in fixative with 25 or 30% sucrose and stored 
at 4°C. The following day the cerebellum was removed. In some 
cases the cortex was also removed. The brainstem or brainstem and 
cortex were frozen and cut in the transverse or sagittal plane on a 
sliding microtome into 40–50 μm thick sections. The sections were 
collected serially into six sets.
hIstology
For most cases, in one tissue set (containing every sixth section), the 
tissue sections containing the MG were reacted with cytochrome 
oxidase (CO) for the identification of MG subdivisions (Anderson 
et al., 2007). In some cases, one set was stained with thionin for 
identification of cytoarchitectural borders and landmarks. The 
remaining sets of tissue were used for immunohistochemistry.
Choline aceyltransferase (ChAT) immunohistochemistry was 
used to identify putative cholinergic cells as previously reported 
(Motts et al., 2008) except that primary antibody concentrations 
were increased two- to eight-fold for fluorescence imaging. Briefly, 
sections were incubated (1 day at 4°C) with goat anti-ChAT anti-
body (Chemicon AB 144P, [Millipore, Billerica, MA, USA]) diluted 
1:25–1:100. The sections were then treated with 1% biotinylated rab-
bit anti-goat antibody (BA-5000, Vector Laboratories, Burlingame, 
Table 1 | Summary of experimental parameters.
Case Side Tracer Inj. type Volume Survival time Plane of No. of sections Weight Section thickness 
     (days) section quantified (g) (μm)
GP471 L FG ms 0.05 μl 13 s − 310 40
GP473 L FG ms 0.03 μl 11 s − 415 40
GP480 R FG ms 0.05 μl 10 t − 468 40
GP481 R GB ms 0.4 μl 6 t − 317 50
GP482 L FG ms 0.05 μl 6 t 8 300 50
GP484 R GB ms 0.2 μl 9 t 5 393 50
GP579 L FG mp 13.8 nl 4 t 8 316 50
GP585 L GB mp 69 nl 25 t 9 439 40
 R RB mp 69 nl 25 t 9  
GP586 R RB mp 69 nl 25 t 6 419 40
GP587 L GB mp 69 nl 5 t 6 258 40
GP595 L GB mp 69 nl 7 t 8 401 50
 R RB mp 69 nl 7 t 8  
GP604 L FG ms 0.05 μl 11 t 10 367 50
Red beads (RB; Luma-Fluor, Inc., Naples, FL, USA), green beads (GB; Luma-Fluor, Inc.), and FluoroGold (FG; FluoroChrome, Inc., Englewood, CO, USA) were used 
as retrograde fluorescent tracers. Injection type was either by a 1-μl Hamilton microsyringe (ms) or by a Nanoliter Injector (World Precision Instruments), with a glass 
micropipette (mp) with an inside tip diameter of 25–35 μm. For the FG mp injection (GP579), one pulse was used to inject the tracer, and the micropipette was left in 
place for 5 min before it was withdrawn. For the remaining mp injections, 5 pulses of 13.8 nl were given, with a 1–5 min pause after each pulse. Each microsyringe 
was used only for a single tracer. In some animals, a different tracer was placed into left and right MG to obtain two experiments from each animal. Plane of section 
was either sagittal (s) or transverse (t). Number of sections quantified indicates the number of sections in the series that were quantified (and contained PMT).
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CA, USA) and labeled with streptavidin conjugated to a fluorescent 
marker (AlexaFluor 488 [green] or AlexaFluor 647 [near-infrared]; 
Invitrogen, Carlsbad, CA, USA) that could be distinguished from 
the tracers used in the case. The sections were mounted on gelatin-
coated slides, air dried, and coverslipped with DPX (Sigma).
data analysIs
A Neurolucida reconstruction system (version 8; MBF Bioscience, 
Williston, VT, USA) attached to a Zeiss Axioplan II microscope 
(Carl Zeiss, Inc., Thornwood, NY, USA) was used to plot labeled 
cells, nuclear borders, and injection sites. Plots were exported to 
Adobe Illustrator CS2 (Adobe Systems, Inc., San Jose, CA, USA) 
for final figure construction.
The brainstem cholinergic nuclei (PPT and LDT) in guinea pigs 
have been described in detail previously (Leonard et al., 1995; Motts 
et al., 2008). Some of the borders of the PPT and the LDT are indis-
tinct in a thionin stain, so the distribution of ChAT-immunopositive 
cells was used to define the extent of the nuclei.
A Zeiss AxioImager Z1 fluorescence microscope with AxioCam 
HRm (monochrome) and HRc (color) cameras (Zeiss) was used to 
take photomicrographs. Monochrome images, including all images 
of AlexaFluor 647, which fluoresces at near infrared wavelengths, 
were pseudocolored either with the camera software (AxioVision 
4.6, Zeiss) or with Photoshop CS2. Adobe Photoshop CS2 was 
used to add scale bars and labels, scale, and crop images, erase 
background around tissue sections, and adjust intensity levels in 
photomicrographs.
Three criteria were used to select cases for quantitative summary. 
First, sections had to be free from tissue damage that would prevent 
assessment of injection sites and areas of retrogradely labeled cells. 
Second, the ChAT immunostain had to be bright and even across 
sections. Third, there had to be at least 50 retrogradely labeled PMT 
cells in a bin (every sixth section). Of the 12 animals used for this 
study, results from 8 animals met the criteria to be included in the 
quantitative summary. All of the cases used for quantitative analysis 
and illustration were cut in the transverse plane. Table 1 shows the 
experimental parameters for each case.
results
We combined retrograde tracing and immunohistochemistry to 
identify the cholinergic and non-cholinergic PMT inputs to the 
MG. The patterns of labeled cells were similar qualitatively for the 
different tracers and different survival times used in this study. 
Our experiments included both large injections that involved sev-
eral MG subdivisions, and smaller injections, which were largely 
confined to one or two subdivisions (Figure 1).
A large injection labeled many cells in the PMT and in numer-
ous areas associated with the brainstem auditory pathways. The 
latter areas included the cochlear nucleus, superior olivary complex, 
ventral nucleus of the lateral lemniscus and adjacent paralemniscal 
area, nucleus sagulum, and a region dorsal to the dorsal nucleus 
of the lateral lemniscus (where a collection of cholinergic cells 
stretches from the PPT to the laterally placed nucleus sagulum). 
Among all these regions, only the nuclei of the PMT contained 
retrogradely labeled cells that were also immunopositive for ChAT 
(Figure 2). The remainder of this paper focuses on the retrogradely 
labeled cells within the PMT.
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FIGure 1 | Photomicrographs of medial geniculate body (MG) 
subdivisions and representative tracer injection sites in transverse 
sections. (A) Section stained with cytochrome oxidase (CO) showing the 
subdivisions of MG: dl, dorsolateral; m, medial; s, shell; sg, suprageniculate; v, 
ventral. (B) Injection of red beads that is centered in the ventral MG (v) and 
extends into the dorsolateral subdivision (dl). This photomicrograph is of the 
right MG, but was flipped to make comparisons between the cases easier. GP 
595R. (C) Injection of green beads confined to the ventral subdivision. The 
image is an overlay of a fluorescence image to visualize the GB and a 
brightfield image to show the CO counterstain. GP 587L. (D) An injection of 
red beads within the suprageniculate subdivision (sg). This photomicrograph is 
of the right MG, but was flipped to make comparisons between the cases 
easier. GP 586R. Scale bars = 0.5 mm for A–D.
FIGure 2 | Photomicrographs of labeled cells in the PMT after injections in 
MG. In each panel the left image shows cells labeled with retrograde tracer [green 
beads for A–C (GP 585L), FluoroGold for D (GP 484L)]. The right image shows the 
same field of view filtered for ChAT immunolabel. Arrowheads indicate cells 
labeled with both tracer and immunolabel; arrows indicate cells labeled with tracer 
only. (A,B) PPT cells projecting to the ipsilateral MG. (C) PPT cell projecting to the 
contralateral MG. (D) LDT cell projecting to contralateral MG. All 
photomicrographs are taken from transverse sections. Scale bar = 10 μm.
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in guinea pigs (Motts et al., 2008), and we used the same fixa-
tion and tissue processing parameters as in the previous study. We 
see clearly labeled cells in the expected areas, such as the cranial 
nerve motor nuclei. We conclude that the immunolabeled cells 
are cholinergic.
It is always possible that an immunohistochemical assay will fail 
to label every cell that contains the antigen. However, we obtained 
immunopositive and immunonegative retrogradely labeled cells 
within the same focal plane (Figure 2), suggesting that the immu-
nolabeling reagents penetrated the tissue and that the immu-
nonegative cells are likely to be non-cholinergic. In addition to 
cholinergic cells, the PPT and the LDT contain GABAergic and 
glutamatergic cells (Vincent et al., 1986; Lavoie and Parent, 1994; 
Ford et al., 1995; Leonard et al., 1995; Jia et al., 2003; Wang and 
Morales, 2009). It is likely that cells of either or both of these types 
were among our immunonegative cells. Future studies are neces-
sary to identify the non-cholinergic cell types and determine their 
contributions to the PMT projections. This information will help 
in understanding the effects of the PMT projection to the MG 
across the sleep-wake cycle.
Two final issues relate to the injections. First, some injections 
spread beyond the MG. Other thalamic nuclei are innervated by the 
PMT, and we would expect that some of the cells labeled in these 
cases terminate outside the MG. However, small injections confined 
to the MG produce a distribution of retrogradely labeled cells that 
was similar to that after the larger injections. We conclude that the 
quantitative differences between our cases with small injections ver-
sus the large injection reflect specifics of the PMT projection to the 
MG. More meaningful comparison will require future experiments 
with small injections confined to other thalamic nuclei.
A related issue concerns the possibility of labeling axons of pas-
sage whereby injections in the caudal thalamus, where the MG is 
located, could label PMT cells that project to more rostral thalamic 
(or extrathalamic) targets. We have used red beads and green beads 
in many of our experiments. These tracers are less likely than other 
tracers to be taken up by axons of passage (Katz and Iarovici, 1990). 
In addition, we have used micropipettes for some of our injections. 
Micropipettes cause less damage than syringes, thus decreasing the 
likelihood of tracer uptake by axons of passage. While we cannot 
rule out the possibility of labeling PMT cells that project outside 
the MG, we believe that such cells were in the minority and are 
unlikely to alter the main conclusions.
functIonal IMPlIcatIons
Our results are generally consistent with previous studies that the 
MG is a target of brainstem cholinergic cells (Hallanger et al., 1987; 
Steriade et al., 1988). These results are very similar to those in cats 
(Steriade et al., 1988) but differ from those in rats, where both 
anterograde and retrograde experiments failed to label a projection 
from the LDT to the MG (Satoh and Fibiger, 1986; Hallanger et al., 
1987; Cornwall et al., 1990). Our results demonstrate both cholin-
ergic and non-cholinergic projections from the LDT to the MG in 
guinea pigs. The LDT projections are bilateral with an ipsilateral 
dominance, and involve fewer cells than the projections from the 
PPT. Additional experiments will be needed to determine whether 
the apparent differences in rats are due to the species or to differ-
ences in methods.
The distribution of labeled cells in the PMT after a large FG 
injection is illustrated in Figure 3A. This case (GP 604L) had a 
large injection in the left MG that almost completely filled the 
dorsolateral subdivision and included significant portions of the 
medial, suprageniculate, and ventral subdivisions. A small part of 
the shell region was included in the injection as well. The injection 
spread dorsally and rostrally beyond MG to include the dorsal lat-
eral geniculate and lateral posterior nuclei. We found retrogradely 
labeled cells in the PPT and the LDT on both sides. More labeled 
cells were present on the ipsilateral side and, on each side, more 
were present in the PPT than the LDT. In each of the nuclei, some 
of the retrogradely labeled cells were ChAT immunopositive; over-
all, these constituted 53% of the retrogradely labeled cells in PMT 
(Table 2). In each nucleus, immunonegative cells were located near 
immunopositive cells, suggesting that the immunostain was effec-
tive in the area and that the tracer-labeled, immunonegative cells 
were non-cholinergic (Figure 2). Together, these data indicate that 
both cholinergic and non-cholinergic PMT cells contribute to the 
projection to the MG.
Interpretation of the results just described is complicated by 
spread of the injection into areas surrounding the MG, which also 
receive inputs from the PMT nuclei (Steriade et al., 1988). We now 
describe results from smaller injections; two of these were confined 
entirely to the MG and the remainder had only slight spread outside 
the MG (Table 2). Figure 3B shows an injection in the MGv and 
resulting label in PMT. Figure 3C shows an injection in the supra-
geniculate subdivision of the MG and resulting label. In both cases, 
the results were qualitatively similar to large injections. Quantitative 
analysis revealed some additional points (Table 2; Figure 4). The 
LDT contained double-labeled cells in every case, although they 
were relatively few and not always present bilaterally. While the 
percentage of ChAT-immunopositive cells varied (11–65%), it was 
not possible to relate the variation to the location of the injection; 
e.g., the 3 highest percentages for ChAT+ cells were associated with 
injections in the MGv, but so was the lowest value. The reasons for 
the variation are not clear. Across the nine experiments with small 
injections, 44% of the retrogradely labeled cells in the PMT were 
ChAT immunopositive (compared to 53% after the large injec-
tion). In fact, the ipsilateral PPT was the only nucleus in which the 
retrogradely labeled ChAT-immunopositive cells outnumbered the 
retrogradely labeled ChAT-immunonegative cells on average. This 
suggests that non-cholinergic cells may be more prominent in the 
PMT projections to the MG than to other thalamic nuclei.
dIscussIon
Our results show that both the PPT and the LDT are sources of 
cholinergic input to the MG in guinea pigs. In addition, a sizable 
non-cholinergic projection to the MG also arises in the PPT and 
the LDT. We first address the technical issues of our experiments. 
We then discuss our data in the context of previous studies and the 
functional significance of the projections.
technIcal consIderatIons
We used an antibody against ChAT as a marker for cholinergic cells. 
ChAT is considered a specific marker for cholinergic cells (Levey 
and Wainer, 1982; Armstrong et al., 1983; German et al., 1985; 
Maley et al., 1988). The antibody has been validated  previously 
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FIGure 3 | Plots of labeled cells in the PMT after large (A) or small (B,C) 
injections in the thalamus. (A) Drawings of transverse sections showing a large 
FluoroGold injection (blue shading, sections 1–7 [left side of section only]) in the left 
thalamus and labeled cells in the PMT nuclei (sections 13–17). An entire midbrain 
section is shown (bottom of column) for orientation of brainstem sections. Only the 
portion of tegmentum that included the PPT and the LDT (indicated by box) are 
shown in the remaining sections. The legend indicates the type of label in all 
panels; each symbol represents at least one labeled cell. GP 604L. (B) Drawing 
through the center of a green bead injection site confined to the ventral subdivision 
of the MG. Labeled cells are shown in the PMT at 3 rostro-caudal levels. GP 587L. 
(C) Drawing through the center of a red bead injection in the MG suprageniculate 
subdivision, and resulting label in the PMT. The drawings were flipped to make 
comparisons between the cases easier. GP 586R. In all panels, the sections are 
numbered from rostral to caudal with each whole number representing a 300-μm 
spacing. The extent of the PPT and LDT nuclei are indicated by the distribution of 
the ChAT immunopositive cells (green triangles). The ChAT immunopositive cells 
within the periaqueductal gray (PAG) are in the LDT; the ChAT immunopositive cells 
outside the PAG are in the PPT. The superior cerebellar peduncle is shown in gray as 
it is a helpful landmark for the PPT. APT, anterior pretectal nucleus; Aq, aqueduct; 
CG, central gray; dl, dorsolateral subdivision of MG; DLL, dorsal nucleus of lateral 
lemniscus; Ha, habenula; IC, inferior colliculus; LDT, laterodorsal tegmental nucleus; 
lfp; longitudinal fasciculus of the pons; LG, lateral geniculate body; LP, lateral 
posterior nucleus; m, medial subdivision of MG; mlf, medial longitudinal fasciculus; 
Mo5, motor nucleus of 5th nerve; PAG, periaqueductal gray; PBG, parabigeminal 
nucleus; PnO, pontine reticular nucleus, oral part; Po, posterior nucleus of the 
thalamus; PPT, pedunculopontine tegmental nucleus; Pul, pulvinar nucleus; RtTg, 
reticulotegmental nucleus of the pons; s, shell subdivision of MG; SC, superior 
colliculus; scp, superior cerebellar peduncle; sg, suprageniculate subdivision of 
MG; SN, substantia nigra; v, ventral subdivision of MG; xscp, decussation of scp; 
ZI, zona incerta.
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Another quantitative difference relates to the percentage of 
the PMT projection that is cholinergic. Previous reports have 
described the PMT projection to MG as up to 85% cholinergic in 
cats (Steriade et al., 1988), and PMT projections to the thalamus in 
general as 91% cholinergic (Sofroniew et al., 1985). However, our 
data in guinea pigs show only 44% of the projection is cholinergic 
(Table 2). It is possible that our immunostaining did not label every 
cholinergic cell. Another issue here is how one defines the borders 
of the PMT nuclei. Many of these borders, especially for the PPT, 
are difficult to identify. We use an operational definition based 
on the distribution of the presumptive cholinergic cells (Leonard 
et al., 1995). Small differences between species in the distribution 
of different cell types could lead to inclusion of more or fewer 
non-cholinergic cells within the PPT border. As mentioned above, 
there is growing evidence for important roles of the non-cholinergic 
projections from these areas (e.g., Boucetta and Jones, 2009). Future 
experiments designed to identify the neurotransmitters used by 
presumptive non-cholinergic cells will be necessary both to provide 
insight into functions and to clarify the relative contributions of 
different transmitters to the PMT projection.
It is likely that all MG subdivisions receive both cholinergic 
and non-cholinergic inputs from PMT. All subdivisions of the 
MG contain nicotinic and muscarinic receptors (Schwartz, 1986). 
However, there are reports that principle sensory nuclei can have 
a non-uniform distribution of ChAT immunopositive axons (e.g., 
Fitzpatrick et al., 1989). All of our injections, regardless of subdivi-
sions involved, labeled cholinergic and non-cholinergic cells. We 
do not have sufficient numbers of cases with injections restricted 
to single subdivisions to make conclusions about the types of PMT 
cells (cholinergic or non-cholinergic) that contribute to the projec-
tion to each MG subdivision. Even with such data, this issue will 
benefit from examination of cholinergic axons in the MG.
The PMT projections to the thalamus have long been recognized 
as important for the generation of the REM component of sleep 
(Rye, 1997). While the cholinergic component has received the most 
attention, recently the non-cholinergic PPT and LDT contributions 
to the sleep-wake cycle have been considered (Boucetta and Jones, 
2009). The authors suggested that the cholinergic, GABAergic, and 
glutamatergic cells act in concert to modulate sleep-wake cycles. 
These projections presumably control the flow of information 
through the thalamus in relation to the various stages of the sleep 
wake cycle as well as different levels of vigilance during waking. 
Our data show that cholinergic and non-cholinergic cells project 
to the MG, suggesting that multiple transmitters could modulate 
the MG during the sleep-wake cycle. This suggestion is consistent 
with physiological studies of MG activity during different phases 
of the sleep-wake cycle (Edeline, 2003; Hennevin et al., 2007).
It is possible that the PMT projections serve additional functions 
as well. Approximately half of the cells in both the PPT and LDT 
respond to sound (Reese et al., 1995a,b), suggesting a substantial 
auditory role for these nuclei. In addition to their projections to 
the MG, the PPT and LDT also project to the inferior colliculus 
(Motts and Schofield, 2009) and the cochlear nucleus (Motts and 
Schofield, 2005). The PPT and LDT are also the targets of descend-
ing projections from the auditory cortex (Schofield and Motts, 
2009). The cortical projections appear to contact cholinergic PMT 
cells that project to the IC (Schofield, 2010), suggesting that the Ta
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cortex can modify the level of cholinergic input to some  subcortical 
auditory centers. Such projections might allow the cortex to modu-
late activity in subcortical centers according to the salience of a 
recent acoustic stimulus. In this regard, it would be interesting to 
determine whether the cortical projections also contact PMT cells 
(cholinergic or otherwise) that project to the MG.
Pontomesencephalic tegmentum cells are also involved in pre-
pulse inhibition of startle via cholinergic projections to the caudal 
pontine nuclei (Koch et al., 1993). Prepulse inhibition has been 
viewed as a form of gating that allows the auditory system to con-
tinue processing acoustic information without the interruption 
that would be induced by a startle response. It will be of  particular 
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FIGure 4 | Graphs to illustrate the contribution of ipsilateral and 
contralateral PPT and LDT to the overall projection to MG. Tracer-labeled 
cells were counted in every sixth section and tallied according to whether they 
were ChAT+ or ChAT−. The results are expressed as a percentage of the total 
number of tracer-labeled cells. (A) Results from a very large injection (GP604L). 
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